EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Remodeling of non-coding RNA regulatory networks: Decoding the pathological mechanisms and new therapeutic paradigms of cardiovascular diseases

Wangzheqi Zhang, Lei Duan, Changli Wang, Yan Liao, Rui Zhao, Zhaoyu Li, Haoling Zhang, Zengwu Wang, Jing-Jing Zhang

Physics of Life Reviews · 2026-03 · 56 · 131-201

DOI: 10.1016/j.plrev.2025.12.007 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Physics of Life Reviews, 2026-03. Verfasst von Wangzheqi Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Anesthesiology, Changhai Hospital, Naval Medical University, Shanghai, 200433 China. Hauptthemen laut MEDLINE: Cardiovascular Diseases, RNA, Untranslated, Gene Regulatory Networks. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 678 Literaturangaben. Gefördert von: Yunnan Provincial Science and Technology Department, Kunming Medical University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The essential role of non-coding RNAs (ncRNAs) in cardiovascular disease (CVD) research instigates a shift from empirical studies to those based on molecular mechanisms, targeted interventions, and personalized health management in the world of precision medicine. This review systematically summarizes the expression profiles and multilayered regulatory mechanisms of various ncRNAs such as microRNAs (miRNAs), long non-coding RNAs (lncRNAs), circular RNAs (circRNAs), and small nucleolar RNAs (snoRNAs) in a variety of cardiovascular diseases (CVDs) ranging from congenital heart disease to atherosclerosis (AS), cardiomyopathies, heart failure (HF), and arrhythmias. The central roles of key pathological pathways like epigenetic changes, competing endogenous RNA (ceRNA), inflammation and cell fate determination will be highlighted. From a diagnostic point of view, ncRNAs have good potentials as early-stage biomarkers, in applications such as exosomal liquid biopsy, disease classification, and prognosis. Emerging technologies, notably locked nucleic acid (LNA) oligonucleotides, adeno-associated virus serotype 9 (AAV9)-based delivery systems and engineered exosomes, are unlocking new avenues for intervention on the therapeutic front. These developments, coupled with drug repurposing strategies and tissue-specific delivery platforms, can make ncRNA-targeted therapies more specific and controllable. At the same time, interdisciplinary innovations, like single-cell multi-omics, spatial transcriptomics, CRISPR-dCas9 systems, and deep learning assist clinical translation greatly. However, the real-world application of ncRNA-based therapies is constrained by many challenges like low delivery efficiency, functional redundancy, and microenvironmental dependence. Future directions must aim to create integrative platforms that can dynamically identify and modulate ncRNA functions to link mechanistic studies to personalized therapies and subsequently expedite clinical translation of ncRNA discoveries. In this sense, three cross-scale principles-network topology and ceRNA competition dynamics; spatiotemporal gradients modeled by exosome transport and tissue microenvironments; and energetic/stoichiometric constraints like Dicer processing capacity and miRNA-target ratios- provide an analytical framework that appears recurrently across diverse CVD phenotypes and tighten the mechanistic unity of this review.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesRNA, UntranslatedGene Regulatory NetworksHumansAnimals

Stichwörter der Autor:innen

BiomarkersBiophysical constraintsCardiovascular Diseases (CVDs)Clinical TranslationExosomal transportNon-coding RNAs (ncRNAs)Regulatory MechanismsSpatial transcriptomicsTherapeutic StrategiesceRNA dynamics

Substanzen

RNA, Untranslated

Autor:innen und Institutionen

  • Faculty of Anesthesiology, Changhai Hospital, Naval Medical University, Shanghai, 200433 China.
  • Department of Anesthesiology, Xi'an Aerospace Hospital Affiliated of Northwest University, Xi'an City, Shaanxi Province, China.
  • Gansu University of Chinese Medicine, No.35 Dingxi East Road, Lanzhou 730000, Gansu Province, China.
  • College of Acupuncture-Moxibustion and Tuina, Gansu University of Chinese Medicine, No.35 Dingxi East Road, Lanzhou 730000, Gansu Province, China.
  • Department of Biomedical Sciences, Advanced Medical and Dental Institute, Universiti Sains Malaysia, Penang 13200, Malaysia. Electronic address: zhanghaolingedu@163.com.
  • Division of Prevention and Community Health, National Center for Cardiovascular Disease, National Clinical Research center of Cardiovascular Disease, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Pekin…

Förderung

  • Yunnan Provincial Science and Technology Department
  • Kunming Medical University
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, W., Duan, L., Wang, C., Liao, Y., Zhao, R., Li, Z., Zhang, H., Wang, Z., & Zhang, J. J. (2026). Remodeling of non-coding RNA regulatory networks: Decoding the pathological mechanisms and new therapeutic paradigms of cardiovascular diseases. Physics of Life Reviews, 56, 131-201. https://doi.org/10.1016/j.plrev.2025.12.007

Vancouver

Zhang W, Duan L, Wang C, Liao Y, Zhao R, Li Z, et al. Remodeling of non-coding RNA regulatory networks: Decoding the pathological mechanisms and new therapeutic paradigms of cardiovascular diseases. Physics of Life Reviews. 2026;56:131-201. doi:10.1016/j.plrev.2025.12.007

BibTeX
@article{Zhang2026,
  author = {Zhang, Wangzheqi and Duan, Lei and Wang, Changli and Liao, Yan and Zhao, Rui and Li, Zhaoyu and Zhang, Haoling and Wang, Zengwu and Zhang, Jing-Jing},
  title = {Remodeling of non-coding RNA regulatory networks: Decoding the pathological mechanisms and new therapeutic paradigms of cardiovascular diseases},
  journal = {Physics of Life Reviews},
  year = {2026},
  volume = {56},
  pages = {131--201},
  doi = {10.1016/j.plrev.2025.12.007}
}
Kostenlos starten →